Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)

China flag China · Delayed Price · Currency is CNY
51.48
-0.12 (-0.23%)
Aug 6, 2025, 1:45 PM CST
-0.23%
Market Cap31.83B
Revenue (ttm)1.24B
Net Income (ttm)716.42M
Shares Out616.79M
EPS (ttm)1.16
PE Ratio44.48
Forward PE103.89
Dividend0.12 (0.24%)
Ex-Dividend DateJun 13, 2025
Volume3,038,470
Average Volume8,697,059
Open51.71
Previous Close51.60
Day's Range51.16 - 52.48
52-Week Range15.22 - 68.68
Beta0.67
RSI43.61
Earnings DateAug 30, 2025

About Lions Gate Entertainment

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs. Its products include YISAIPU, a tumor necrosis factor inhibitor type II-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Septin, an injection for anti-human epidermal growth factor receptor-2 treatment; and Jiannipa, a recombinant anti-CD25 humanized monoclonal antibody injection to prevent acute rejection caused by kidney transplantation. The company... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 995
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688336
Full Company Profile

Financial Performance

In 2024, SHA:688336's revenue was 1.19 billion, an increase of 17.70% compared to the previous year's 1.01 billion. Earnings were 704.58 million, an increase of 139.15%.

Financial Statements

News

There is no news available yet.